Herbert Virgin - 09 Aug 2022 Form 4 Insider Report for Vir Biotechnology, Inc. (VIR)

Reporting relationship: EVP, Research & CSO
Issuer ticker: VIR
Reported as of: 09 Aug 2022
Net transaction value: +$189,658
SEC form: 4
Accepted by SEC: 10 Aug 2022, 16:50:49 UTC
Prior SEC filing: 11 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Howard Horn, Attorney-in-Fact

Key filing fact

Herbert Virgin filed Form 4 for Vir Biotechnology, Inc. (VIR) on 10 Aug 2022.

Key facts

This page summarizes Herbert Virgin's Form 4 filing for Vir Biotechnology, Inc. (VIR).
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 10 Aug 2022, 16:50.

Change

Previous filing in this sequence was filed on 11 Mar 2022.
Current net transaction value: +$189,658.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VIR transaction

Common Stock

Options Exercise

Transaction value: $107,371
Shares: +70,177
Change %: +38%
Price: $1.53^*
Shares after: 254,584
Date: 09 Aug 2022
Ownership: Direct

VIR transaction

Common Stock

Options Exercise

Transaction value: $82,287
Shares: +7,916
Change %: +3.1%
Price: $10.40
Shares after: 262,500
Date: 09 Aug 2022
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VIR transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -70,177
Change %: -33%
Price: $0.000000
Shares after: 140,328
Date: 09 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 70,177
Exercise price: $1.53
Footnotes: F1

VIR transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -7,916
Change %: -5.9%
Price: $0.000000
Shares after: 125,416
Date: 09 Aug 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 7,916
Exercise price: $10.40
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The option is fully vested and exercisable.

Footnote F2

1/4 of the shares subject to the stock option vested and become exercisable on July 12, 2020, and the remaining shares will vest in 36 equal monthly installments thereafter.